President Trump's FDA appointee, Dr. Marty Makary, has not revealed his opinion on the abortion pill mifepristone, sparking concerns about its future. The pill, used in most U.S. abortions, faces uncertainty as safety protocols and restrictions may change.
FDA Commissioner's Stance on Mifepristone Raises Concerns Over Abortion Access
✨ Enjoying this article? ✨
📱 Get more with the NewsNuggs iOS App →